Tower Research Capital LLC (Trc) Merus N.V. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Merus N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 188 shares of MRUS stock, worth $18,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188

Previous 416 54.81%

Holding current value

$18,038

Previous $21,000 19.05%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$52.33 - $94.15 $11,931 - $21,466	-228 Reduced 54.81%	188 $17,000
Q2 2025 Aug 14, 2025	SELL	$34.89 - $62.42 $84,573 - $151,306	-2,424 Reduced 85.35%	416 $21,000
Q1 2025 May 15, 2025	BUY	$39.01 - $49.16 $6,709 - $8,455	172 Added 6.45%	2,840 $119,000
Q4 2024 Feb 13, 2025	SELL	$41.45 - $54.5 $382,210 - $502,544	-9,221 Reduced 77.56%	2,668 $112,000
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $414,752 - $517,144	8,789 Added 283.52%	11,889 $593,000

Q2 2024 Aug 13, 2024	BUY	$39.81 - $60.2 $103,386 - $156,339	2,597 Added 516.3%	3,100 $183,000
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $45,324 - $83,792	-1,617 Reduced 76.27%	503 $22,000
Q4 2023 Feb 13, 2024	BUY	$20.06 - $28.66 $16,609 - $23,730	828 Added 64.09%	2,120 $58,000
Q3 2023 Nov 14, 2023	SELL	$20.13 - $27.29 $203,675 - $276,120	-10,118 Reduced 88.68%	1,292 $30,000
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $173,071 - $256,633	9,442 Added 479.78%	11,410 $300,000
Q1 2023 May 09, 2023	BUY	$14.25 - $20.5 $3,505 - $5,043	246 Added 14.29%	1,968 $36,000
Q4 2022 Feb 10, 2023	SELL	$12.8 - $23.66 $38,080 - $70,388	-2,975 Reduced 63.34%	1,722 $27,000
Q3 2022 Nov 10, 2022	BUY	$18.64 - $28.93 $67,215 - $104,321	3,606 Added 330.52%	4,697 $94,000
Q2 2022 Aug 15, 2022	SELL	$13.98 - $29.25 $31,455 - $65,812	-2,250 Reduced 67.35%	1,091 $25,000
Q1 2022 May 12, 2022	BUY	$23.58 - $30.91 $64,774 - $84,909	2,747 Added 462.46%	3,341 $88,000
Q4 2021 Feb 14, 2022	SELL	$20.0 - $32.29 $27,480 - $44,366	-1,374 Reduced 69.82%	594 $19,000
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $32,432 - $53,588	1,968 New	1,968 $43,000
Q1 2021 May 17, 2021	SELL	$16.14 - $29.11 $21,433 - $38,658	-1,328 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.4 - $18.36 $15,139 - $24,382	1,328 New	1,328 $23,000
Q3 2020 Nov 16, 2020	SELL	$10.57 - $16.0 $4,217 - $6,384	-399 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$10.5 - $17.36 $15,288 - $25,276	-1,456 Reduced 78.49%	399 $6,000
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $2,199 - $3,771	-194 Reduced 9.47%	1,855 $22,000
Q4 2019 Feb 07, 2020	SELL	$14.08 - $18.5 $9,053 - $11,895	-643 Reduced 23.89%	2,049 $29,000
Q3 2019 Nov 05, 2019	BUY	$14.55 - $20.52 $39,168 - $55,239	2,692 New	2,692 $48,000

Others Institutions Holding MRUS

# of Institutions

274

Shares Held

63.8M

Call Options Held

1.65M

Put Options Held

758K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $4.4B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Merus N.V. Transaction History